PAEDIATRIC CONSUMER HEALTH IN CHINA

Euromonitor International

February 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

the Two-child Policy Continues To Reap Rewards for Paediatric Consumer Health

Improving Health Awareness Amongst Parents Drives Demand

Prevention Rather Than Cure

Competitive Landscape

Biostime Maintains Its Lead in Paediatric Consumer Health

New Product Launches

Fierce Competitive Landscape Seen in the Review Period

Category Data

Table 1 Sales of Paediatric Consumer Health by Category: Value 2013-2018

Table 2 Sales of Paediatric Consumer Health by Category: % Value Growth 2013-2018

Table 3 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2018

Table 4 NBO Company Shares of Paediatric Consumer Health: % Value 2014-2018

Table 5 LBN Brand Shares of Paediatric Consumer Health: % Value 2015-2018

Table 6 Forecast Sales of Paediatric Consumer Health by Category: Value 2018-2023

Table 7 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2018-2023

Executive Summary

Healthy Living Continues To Drive Growth in Consumer Health in China

Supportive Government Policies Continue To Propel Growth

Mergers and Acquisitions Lead To A Dynamic Competitive Landscape

the Integration of Online and Offline Sees Strong Potential

Steady Growth Expected for Consumer Health Over the Forecast Period

Market Indicators

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 9 Life Expectancy at Birth 2013-2018

Market Data

Table 10 Sales of Consumer Health by Category: Value 2013-2018

Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 14 Distribution of Consumer Health by Format: % Value 2013-2018

Table 15 Distribution of Consumer Health by Format and Category: % Value 2018

Table 16 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Summary 1 OTC: Switches

Definitions

Sources

Summary 2 Research Sources

In 2018, paediatric consumer health in China recorded double-digit current value growth, driven by the successive benefits of the two-child policy widely executed by the Chinese national government since 2016. As the National Bureau of Statistics of the People’s Republic of China announced in early 2018, the new-born population reached approximately 17.2 million during 2017, with a 12.43% birth rate. With the expanding number of new-borns, paediatric consumer health products, including both self...

Euromonitor International's Paediatric Consumer Health in China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Paediatric Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.